(Q46604957)

English

Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia

scientific article published on 9 May 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia (English)

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Frank Schneider

13

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

Joachim Klosterkötter

9

object named as

Joachim Klosterkötter

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

Hans-Jürgen Möller

1

object named as

Hans-Jürgen Möller

1 reference

Europe PubMed Central

23 December 2017

Gerhard Buchkremer

7

object named as

Gerhard Buchkremer

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

2

object named as

Michael Riedel

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

Ralf G. Schlösser

12

object named as

Ralf Schlösser

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

Christian Ohmann

14

object named as

Christian Ohmann

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

author name string

Markus Jäger

3

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

Florian Wickelmaier

4

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

Wolfgang Maier

5

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

Kai-Uwe Kühn

6

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

Isabella Heuser

8

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

Markus Gastpar

10

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

Dieter F Braus

11

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

Mathias Riesbeck

15

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

Wolfgang Gaebel

16

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

publication date

9 May 2008

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

number of pages

13

1 reference

based on heuristic

inferred from page(s)

The International Journal of Neuropsychopharmacology

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

11

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

7

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

985-997

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

Statistics notes: Analysing controlled trials with baseline and follow up measurements

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

The Prognosis of Schizophrenia: Rationale for a Multidimensional Concept*

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

Prognostic variables at intake and long-term level of function in schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

Intraclass correlations: uses in assessing rater reliability

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

Olanzapine and haloperidol in first episode psychosis: two-year data

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

Olanzapine versus haloperidol treatment in first-episode psychosis

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

A randomized, controlled comparison of the efficacy and tolerability of low and high doses of haloperidol in the treatment of first-episode psychosis

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

Negative symptoms in schizophrenia: considerations for clinical trials. Working group on negative symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

Risperidone in the treatment of first-episode psychotic patients: a double-blind multicenter study. Risperidone Working Group

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

Psychopathological and social outcome in schizophrenia versus affective/schizoaffective psychoses and prediction of poor outcome in schizophrenia. Results from a 5-8 year follow-up

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

The Kraepelinian dichotomy: preliminary results of a 15-year follow-up study on functional psychoses: focus on negative symptoms

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

Medication adherence of individuals with a first episode of psychosis

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

Clinical evaluation of negative symptoms in schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

Antidepressive effects of traditional and second generation antipsychotics: a review of the clinical data

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

Negative symptoms in schizophrenia. Definition and reliability

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

Course and long-term treatment of schizophrenic psychoses

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

Management of the negative symptoms of schizophrenia: new treatment options

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

State of the art of drug treatment of schizophrenia and the future position of the novel/atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

Definition, psychopharmacological basis and clinical evaluation of novel/atypical neuroleptics: methodological issues and clinical consequences

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

Maintenance treatment of schizophrenia with risperidone or haloperidol: 2-year outcomes

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

A rating scale for mania: reliability, validity and sensitivity

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

21 January 2018

Optimal haloperidol dosage in first-episode psychosis.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

7 January 2021

based on heuristic

inferred from DOI database lookup

German research network on schizophrenia-bridging the gap between research and care

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

7 January 2021

based on heuristic

inferred from DOI database lookup

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

7 January 2021

based on heuristic

inferred from DOI database lookup

Premorbid and onset features of first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

7 January 2021

based on heuristic

inferred from DOI database lookup

The Calgary Depression Rating Scale for Schizophrenia: development and interrater reliability of a German version (CDSS-G)

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term course of schizophrenic, affective and schizoaffective psychosis: focus on negative symptoms and their impact on global indicators of outcome

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

7 January 2021

based on heuristic

inferred from DOI database lookup

A depression rating scale for schizophrenics

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

7 January 2021

based on heuristic

inferred from DOI database lookup

Risperidone, 2 mg/day vs. 4 mg/day, in first-episode, acutely psychotic patients: treatment efficacy and effects on fine motor functioning.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

7 January 2021

based on heuristic

inferred from DOI database lookup

The serotonin paradox: Negative symptoms and SSRI augmentation

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008791

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S1461145708008791

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18466670

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46604957&oldid=2121708068"